Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Opko Health Inc (OPK)

Opko Health Inc (OPK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Is OPKO Health a Diagnostics Stock Worth Buying?

Multinational biopharmaceutical company OPKO Health's (OPK) stock climbed nearly 13% in price last year when the company announced its plans to acquire ModeX Therapeutics. However, given the company's...

A : 121.29 (+2.27%)
CO : 3.33 (-2.92%)
OPK : 2.64 (+0.38%)
QGEN : 46.63 (+4.02%)
OPKO Health (OPK) Post In-Line Q1 Earnings, Revenues Top

OPKO Health's (OPK) first-quarter results benefit from continued strength in its Pharmaceuticals segment.

OMCL : 121.69 (+3.46%)
MASI : 138.60 (+2.19%)
AMN : 106.12 (+1.47%)
OPK : 2.64 (+0.38%)
Why Opko Health Stock Is Jumping Today

The company topped Q1 revenue estimates and announced a key new acquisition.

OPK : 2.64 (+0.38%)
Opko Health (OPK) Q1 2022 Earnings Call Transcript

OPK earnings call for the period ending March 31, 2022.

OPK : 2.64 (+0.38%)
OPKO Health (OPK) Reports Q1 Loss, Tops Revenue Estimates

OPKO Health (OPK) delivered earnings and revenue surprises of 0% and 6.28%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

OPK : 2.64 (+0.38%)
AWH : 0.5144 (-0.31%)
OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases

Dr. Elias Zerhouni, ModeX Chairman, former President of Global R&D at Sanofi and former NIH Director, named President and Vice Chairman of OPKODr. Gary...

OPK : 2.64 (+0.38%)
Penumbra (PEN) Reports Q1 Loss, Tops Revenue Estimates

Penumbra (PEN) delivered earnings and revenue surprises of -116.67% and 4.03%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

PEN : 131.75 (+3.27%)
OPK : 2.64 (+0.38%)
Intuitive Surgical, Inc. (ISRG) Tops Q1 Earnings and Revenue Estimates

Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of 5.61% and 3.30%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ISRG : 209.67 (+2.53%)
OPK : 2.64 (+0.38%)
OPK May 27th Options Begin Trading

Investors in OPKO Health Inc saw new options begin trading today, for the May 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the OPK options chain for the new...

OPK : 2.64 (+0.38%)
Reasons to Retain OPKO Health (OPK) Stock in Your Portfolio

Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in Rayaldee and regulatory approvals.

MDRX : 15.50 (+2.04%)
HSIC : 77.29 (+2.02%)
AMN : 106.12 (+1.47%)
OPK : 2.64 (+0.38%)

Barchart Exclusives

Microsoft Stock Offers a Great Value Equation Here
Microsoft stock offers investors a great value equation here - a good yield, low P/E, earnings growth, and large buybacks equate to a higher price. Buying near-the-money calls are a good way to play it. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar